Small Firms Introduce More Drugs at Lower Costs—Report
Drug price controls in the Inflation Reduction Act (IRA) will not stymie the introduction of new products, because innovative drugs are increasingly being developed and marketed by smaller companies with less capital and revenue than Big Pharma, according …